Investing.com - Vericel Corp Ord (NASDAQ: VCEL) reported first quarter EPS of $-0.16, $0.01 worse than the analyst estimate of $-0.15. Revenue for the quarter came in at $41.01M versus the consensus estimate of $37.88M.
Guidance
Vericel Corp Ord sees FY 2023 revenue of $180.00M-$188.00M versus the analyst consensus of $193.00M.
Vericel Corp Ord's stock price closed at $32.84. It is up 13.79% in the last 3 months and up 28.43% in the last 12 months.
Vericel Corp Ord saw 0 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Vericel Corp Ord's stock price’s past reactions to earnings here.
According to InvestingPro, Vericel Corp Ord's Financial Health score is "good performance".
Check out Vericel Corp Ord's recent earnings performance, and Vericel Corp Ord's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar